About Transmembrane protein 135
Transmembrane protein 135 (TMEM135) is a protein
from Homo sapiens identified by UniProt accession
Q86UB9, 458 residues long.
MolForge cross-references it against 0 known binders and
93 disease associations.
Target properties
| Protein name | Transmembrane protein 135 |
| UniProt accession | Q86UB9 |
| Gene | TMEM135 |
| Organism | Homo sapiens |
| Length | 458 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (93)
Diseases linked to this target (Open Targets).
- heel bone mineral density · score 0.43
- bone quantitative ultrasound measurement · score 0.41
- bone density · score 0.39
- electrocardiography · score 0.37
- alkaline phosphatase measurement · score 0.33
- bone fracture · score 0.29
- cup-to-disc ratio measurement · score 0.27
- velocity of sound measurement · score 0.23
- spine bone mineral density · score 0.23
- ulna fracture · score 0.22
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q86UB9-F1 | alphafold | PREDICTED | 86.53 | — |
Amino-acid sequence (458 residues)
MAALSKSIPH NCYEIGHTWH PSCRVSFLQI TGGALEESLK IYAPLYLIAA ILRKRKLDYY LHKLLPEILQ SASFLTANGA LYMAFFCILR KILGKFYSWT PGFGAALPAS YVAILIERKS RRGLLTIYMA NLATETLFRM GVARGTITTL RNGEVLLFCI TAAMYMFFFR CKDGLKGFTF SALRFIVGKE EIPTHSFSPE AAYAKVEQKR EQHEEKPGRM NMIGLVRKFV DSICKHGPRH RCCKHYEDNC ISYCIKGFIR MFSVGYLIQC CLRIPSAFRH LFTQPSRLLS LFYNKENFQL GAFLGSFVSI YKGTSCFLRW IRNLDDELHA IIAGFLAGIS MMFYKSTTIS MYLASKLVET MYFKGIEAGK VPYFPHADTI IYSISTAICF QAAVMEVQTL RPSYWKFLLR LTKGKFAVMN RKVLDVFGTG ASKHFQDFIP RLDPRYTTVT PELPTEFS
Explore Transmembrane protein 135 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets